Guide to Pharmaceutical Product Quality

作者: Henk G. Merkus

DOI: 10.1007/978-3-319-94174-5_2

关键词:

摘要: Most drug constituents have a particulate nature, the properties of which may be critical for both manufacturing process and final quality. This chapter discusses means to reach maintain optimum quality pharmaceutical products. A scientific basis, as promoted by approach Quality Design (QbD), identification, measurement control attributes products processes, with special attention particle size, shape morphology, provide good opportunities decreasing their development time. In addition, Process Analytical Technology (PAT) framework, promotes application modern analytical instruments chemometric tools monitoring control, offers shorten optimize including changes from batch continuous processes. Thus, stable product result at reduced costs if processes are based on knowledge instrumentation. further summarizes general ICH guidelines Moreover, it aspects some methods techniques size analysis shape, acceptance criteria distributions, well qualification methods, management

参考文章(23)
Yashwant Pathak, Deepak Thassu, Scale Up and Technology Transfer of Pharmaceutical Suspensions Springer, New York, NY. pp. 245- 264 ,(2010) , 10.1007/978-1-4419-1087-5_8
Terence Allen, Particle size measurement ,(1968)
Michael Richard Soames, Image analysis methods ,(1975)
Shewhart Control Charts John Wiley & Sons, Inc.. pp. 97- 124 ,(2012) , 10.1002/9781118491751.CH5
Alan F. Rawle, Instrument Qualification and Performance Verification for Particle Size Instruments Practical Approaches to Method Validation and Essential Instrument Qualification. pp. 255- 298 ,(2012) , 10.1002/9780470630716.CH12
Lawrence X Yu, Robert A Lionberger, Andre S Raw, Rosario D'Costa, Huiquan Wu, Ajaz S Hussain, Applications of process analytical technology to crystallization processes. Advanced Drug Delivery Reviews. ,vol. 56, pp. 349- 369 ,(2004) , 10.1016/J.ADDR.2003.10.012
F.J Muzzio, C.L Goodridge, A Alexander, P Arratia, H Yang, O Sudah, G Mergen, Sampling and characterization of pharmaceutical powders and granular blends. International Journal of Pharmaceutics. ,vol. 250, pp. 51- 64 ,(2003) , 10.1016/S0378-5173(02)00481-7
Haitao Zhang, Richard Lakerveld, Patrick L. Heider, Mengying Tao, Min Su, Christopher J. Testa, Alyssa N. D’Antonio, Paul I. Barton, Richard D. Braatz, Bernhardt L. Trout, Allan S. Myerson, Klavs F. Jensen, James M. B. Evans, Application of Continuous Crystallization in an Integrated Continuous Pharmaceutical Pilot Plant Crystal Growth & Design. ,vol. 14, pp. 2148- 2157 ,(2014) , 10.1021/CG401571H
Salvatore Mascia, Patrick L. Heider, Haitao Zhang, Richard Lakerveld, Brahim Benyahia, Paul I. Barton, Richard D. Braatz, Charles L. Cooney, James M. B. Evans, Timothy F. Jamison, Klavs F. Jensen, Allan S. Myerson, Bernhardt L. Trout, End‐to‐End Continuous Manufacturing of Pharmaceuticals: Integrated Synthesis, Purification, and Final Dosage Formation Angewandte Chemie. ,vol. 52, pp. 12359- 12363 ,(2013) , 10.1002/ANIE.201305429